Announcements Trials
Browse Landscape

Phase

Phase 2/3 2Phase EARLY_PHASE1 1

Status

Unknown 2Completed 1

Sponsor Class

OTHER 66INDUSTRY 34NIH 5FED 3NETWORK 2

Study Type

Interventional 3

Sponsor

Cancer Type

Lymphoid 1Gynecologic 1Dermatologic 1

Conditions

Uterine Cervical Dysplasia 1Lymphoma, T-Cell, Cutaneous 1Bowen's Disease 1

Interventions

Exercise 6pembrolizumab 5enzalutamide 4Docetaxel 4Colonoscopy 4Celecoxib 4sargramostim 3apalutamide 3Prednisone 3Methods 3Leuprolide 3Itraconazole 3Imiquimod 3Granulocyte-Macrophage Colony-Stimulating Factor 3Golytely 3Cryotherapy 3Abiraterone Acetate 32-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 3abiraterone 2Yoga 2Topotecan 2Testosterone 2Tablets 2Simvastatin 2Radiosurgery 2Palliative Care 2Midazolam 2Gelatin 2Decision Support Techniques 2Collagenases 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
FED × Interventional × Imiquimod × Clear all
NCT03116659 2019-08-13

CTCL Directed Therapy

James J. Peters Veterans Affairs Medical Center

Phase EARLY_PHASE1 Unknown
8 enrolled
DermatologicLymphoid

Lymphoma, T-Cell, Cutaneous

NCT02130323 2017-06-27

Topical Imiquimod vs. LEEP for Women With Carcinoma In-situ of the Cervix

United States Naval Medical Center, San Diego

Phase 2/3 Completed
22 enrolled
Gynecologic

Uterine Cervical Dysplasia

NCT00384124 2008-03-26

Topical Imiquimod for Bowen's Disease of the Head and Neck

Brooke Army Medical Center

Phase 2/3 Unknown
50 enrolled

Bowen's Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡